Активируйте JavaScript для полноценного использования elitetrader.ru Проверьте настройки браузера.
Рейтинги акций и pre-market 11 января » Элитный трейдер
Элитный трейдер
Искать автора

Рейтинги акций и pre-market 11 января

11 января 2017 2Капитал margin
Повышен рейтинг акций (Upgraded):

AFL Aflac до Hold от Sell ( Evercore ISI)
ATW Atwood Oceanics до Neutral от Sell ( Citi)
BETR Amplify Snack Brands до Outperform от Neutral ( Consumer Edge)
BKD Brookdale Senior Living до Buy от Hold ( Stifel)
BT BT Group до Overweight от Equal Weight ( Morgan Stanley)
BURBY Burberry до Overweight от Equal Weight ( Barclays)
CCE Coca-Cola European Partners до Buy от Neutral ( UBS)
ENBL Enable Midstream до Outperform от Market Perform ( Wells Fargo)
ESV Ensco до Buy от Neutral ( Citi)
EXPE Expedia до Outperform от Neutral ( Credit Suisse)
GNMK GenMark до Outperform от Market Perform ( Cowen)
GNMK GenMark до Outperform ( Cowen)
KERX Keryx до Neutral от Sell ( Citi)
LRLCY L’Oreal до Buy от Neutral ( UBS)
NBL Noble Energy до Outperform от Market Perform ( BMO Capital)
NE Noble Corp. до Buy от Neutral ( Citi)
PAYX Paychex до Market Perform от Underperform ( Bernstein)
RWEOY RWE AG до Equal Weight от Underweight ( Barclays)
SMLP Summit Midstream до Outperform от Market Perform ( Wells Fargo)
STL Sterling Bancorp до Overweight от Neutral ( Piper Jaffray)
VC Visteon до Outperform on long-term growth ( Credit Suisse)
VC Visteon до Outperform от Market Perform ( Raymond James)
WPZ Williams Partners до Outperform от Market Perform ( Wells Fargo)
WPZ Williams Partners до Strong Buy от Outperform ( Raymond James)
ZION Zions Bancorp до Neutral от Sell ( UBS)

Понижен рейтинг акций (Downgraded):

AHT Ashford Hospitality до Neutral от Outperform ( Baird)
AHT Ashford Hospitality до Neutral ( Baird)
ALGT Allegiant Travel до Hold от Buy ( Stifel)
ARIA ARIAD до Hold от Buy ( SunTrust)
BAC Bank of America до Neutral от Buy ( UBS)
C Citi до Sell от Buy ( UBS)
DVN Devon Energy до Market Perform от Outperform ( Wells Fargo)
EL Estee Lauder до Neutral от Buy ( UBS)
EQT EQT Corporation до Market Perform от Outperform ( BMO Capital)
ESYJY easyJet до Underweight от Neutral ( JPMorgan)
FCB FCB Financial до Neutral от Buy ( UBS)
FHB First Hawaiian до Sell от Neutral ( UBS)
FITB Fifth Third до Sell от Buy ( UBS)
FR First Industrial Realty до Neutral от Outperform ( Baird)
FR First Industrial Realty до Neutral ( Baird)
GEL Genesis Energy до Market Perform от Outperform ( Wells Fargo)
HENKY Henkel до Sell от Neutral ( UBS)
HIMX Himax до Neutral ( Roth Capital)
HIMX Himax до Neutral от Buy ( Roth Capital)
KEY KeyCorp до Neutral от Buy ( UBS)
MMP Magellan Midstream до Market Perform от Outperform ( Wells Fargo)
MTB M&T Bank до Sell от Neutral ( UBS)
NVCR Novocure до Market Perform от Outperform ( Wells Fargo)
NVDQ Novadaq до Market Perform от Outperform ( William Blair)
NVS Novartis до Neutral от Outperform ( Credit Suisse)
OXY Occidental до Market Perform от Outperform ( BMO Capital)
RBGLY Reckitt Benckiser до Neutral от Buy ( UBS)
RF Regions Financial до Sell от Neutral ( UBS)
SALE RetailMeNot до Underperform от Neutral ( Credit Suisse)
SCAI Surgical Care Affiliates до Hold от Buy ( SunTrust)
SHO Sunstone Hotel до Neutral от Outperform ( Baird)
SHO Sunstone Hotel до Neutral ( Baird)
SIEGY Siemens до Sell от Buy ( Goldman)
SMG Scotts Miracle-Gro до Hold от Buy ( SunTrust)
T AT&T до Hold от Buy ( Deutsche Bank)
TCO Taubman Centers до Neutral от Buy ( Goldman)
TMK Torchmark до Sell от Hold ( Evercore ISI)
TRIP TripAdvisor до Neutral от Outperform ( Credit Suisse)
WNRL Western Refining Logistics до Market Perform ( Wells Fargo)
WOOF VCA Inc. до Neutral от Outperform ( Credit Suisse)
XOM Exxon Mobil до Market Perform от Outperform ( Wells Fargo)

Pre-market: ⇑ Derma Sciences (DSCI) +39% поглощение компанией Integra LifeSciences (IART) по цене $7.00 за акций, Enphase Energy (ENPH) +21.2% после объявления о стратегических инвестициях на $10 млн. от T.J. Rodgers and John Doerr, TG Therapeutics (TGTX) +11.5% одобрение FDA препаратов, Achaogen (AKAO) +8% Baker Bros. Advisors приобрел a 13.1% контрольный пакет акций компании, Merck (MRK) +3.3% одобрение препарата от FDA.

⇓ Bristol-Myers (BMY) минус 3.1% на одобрении FDA конкурирующего препарата от компании MRK, Supervalu (SVU) минус 3.6% после квартального отчета, Signet (SIG) минус 4% на разочаровывающих праздничных результатах.